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Abstract
Background: Communication is of paramount importance in responding to health crises. We studied the media
messages put forth by different stakeholders in two Ebola vaccine trials that became controversial in Ghana. These
interactions between health authorities, political actors, and public citizens can offer key lessons for future research.
Through an analysis of online media, we analyse stakeholder concerns and incentives, and the phases of the dispute,
to understand how the dispute evolved to the point of the trials being suspended, and analyse what steps might have
been taken to avert this outcome.
Methods: A web-based system was developed to download and analyse news reports relevant to Ebola vaccine trials.
This included monitoring major online newspapers in each country with planned clinical trials, including Ghana. All
news articles were downloaded, selecting out those containing variants of the words “Ebola,” and “vaccine,” which
were analysed thematically by a team of three coders. Two types of themes were defined: critiques of the trials and
rebuttals in favour of the trials. After reconciling differences between coders’ results, the data were visualised and
reviewed to describe and interpret the debate.
Results: A total of 27,460 articles, published between 1 May and 30 July 2015, were collected from nine different
newspapers in Ghana, of which 139 articles contained the keywords and met the inclusion criteria. The final codebook
included 27 themes, comprising 16 critiques and 11 rebuttals. After coding and reconciliation, the main critiques (and
their associated rebuttals) were selected for in-depth analysis, including statements about the trials being secret
(mentioned in 21% of articles), claims that the vaccine trials would cause an Ebola outbreak in Ghana (33%), and
the alleged impropriety of the incentives offered to participants (35%).
Discussion: Perceptions that the trials were “secret” arose from a combination of premature news reporting and
the fact that the trials were prohibited from conducting any publicity before being approved at the time that the
story came out, which created an impression of secrecy. Fears about Ebola being spread in Ghana appeared in
two forms, the first alleging that scientists would intentionally infect Ghanaians with Ebola in order to test the
vaccine, and the second suggesting that the vaccine might give trial participants Ebola as a side-effect – over the
course of the debate, the latter became the more prominent of the two variants. The incentives were sometimes
criticised for being coercively large, but were much more often criticised for being too small, which may have
been related to a misperception that the incentives were meant as compensation for the trials’ risks, which were
themselves exaggerated.
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Conclusion: The rumours captured through this research indicate the variety of strong emotions drawn out by
the trials, highlighting the importance of understanding the emotional and social context of such research. The
uncertainty, fear, and distrust associated with the trials draw from the contemporary context of the Ebola
outbreak, as well as longstanding historical issues in Ghana. By analysing the debate from its inception, we
can see how the controversy unfolded, and identify points of concern that can inform health communication,
suggesting that this tool may be valuable in future epidemics and crises.
Background
In 2014 the Ebola outbreak in West Africa became a global
health emergency, spurring an international effort to trial
candidate Ebola vaccines and other potential prevention
and control measures. The European Union Innovative
Medicines Initiative (IMI) funded several projects to help
combat the epidemic, one of them EBODAC (EBOla
Vaccine Deployment, Acceptance and Compliance).
Within its broader communication and community
engagement mandate, EBODAC addressed the risk of
misinformation and controversies undermining the trial of
a prime-boost Ebola vaccine regimen, developed by
Janssen Pharmaceutical Companies of Johnson & Johnson
(Janssen). Rumours were already hindering the Ebola
response in the affected countries [1], [2] and the early
detection and analysis of emerging rumours around the
vaccine trials was considered a priority for EBODAC [3].
In February 2015, the EBODAC consortium launched
a system for real-time monitoring and analysis of online
newspapers in Sierra Leone, and in April 2015 the media
monitoring system was extended to include Ghana,
Uganda and Kenya, where Phase I trials for Ebola
vaccines were also being planned.
In late May 2015, a controversy was reported in
Ghanaian newspapers and became inflamed into a pub-
lic debate, finally resulting in the suspension of both
the planned Phase 1 trial for the Janssen Ebola vaccine
at the University of Health and Allied Sciences (UHAS)
in Hohoe, Volta region, and a planned Phase 2 trial for
the GlaxoSmithKline (GSK) Ebola vaccine in Hohoe
and in Kintampo. This controversy was exacerbated by
the fact that, when these critical articles first became
public, both the Minister of Health and the trial lead
investigator were travelling outside Ghana – a fact
which should be borne in mind while reviewing this
analysis.
At the time the controversy broke out, the Ghana
Food and Drugs Authority (FDA) was considering
both vaccine trials for approval. Five months after the
suspension, both vaccine trials were finally approved
by Parliament [4]. To date, however, neither trial has
proceeded since receiving this approval.
This article examines the messages and perspectives
put forth by different stakeholders in the controversial
vaccine trials in Ghana through the use of a media mon-
itoring and analysis system. The study analyses the
stakeholder concerns and incentives, and the phases and
dynamics of the dispute. It provides a unique methodo-
logical approach to studying complex interactions be-
tween public health authorities, political actors, and
public citizens, offering lessons for future research.
Historical research controversies and their implications
History offers several examples of the importance of
addressing stakeholder concerns in public health ini-
tiatives, since failure to do so can undermine health
research and programmes, even when these concerns
are rumour-driven [5–8].
In Nigeria in 2003, for example, Northern states boy-
cotted polio vaccination campaigns, because of a complex
set of factors including the memory of a controversial trial
of the antibiotic Trovan in 1996, in which 11 children died
[9]. Although the deaths were deemed to be unrelated to
the antibiotic, the incident led to a multitude of lawsuits
both in Nigeria and the USA, one of which ended in an
out-of-court settlement of 75 million USD related to
ethical misconduct, paid to the state of Kano in 2009 [10].
The Trovan trial left a lasting distrust in Kano. In 2003
a leader of the polio boycott justified his opposition to
the vaccination campaign by referring to, “…the Pfizer
scandal, when our people were used as guinea pigs with
the approval of the federal ministry of health, and the
approval of all the relevant UN agencies” [11]. A Kano
farmer interviewed in 2005 put the issue more bluntly:
“We cannot trust the white man or our federal
government because many years ago they were in
partnership… Our government does not have our
interests at heart, that is why these people can come in
any time they want and do whatever they want” [12].
This perception that the government responds more to
international interests than to its own people was rein-
forced by the fact that polio vaccines were being provided
free by the Global Polio Eradication Initiative (GPEI),
while services for other pressing health needs were lacking
[13, 14]. The polio boycott, which allowed polio cases to
quadruple between 2002 and 2006, re-seeded the disease
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in multiple countries that had already eliminated it, and
cost the GPEI 500 million USD [15]. This case illustrates
how important it is to recognize and address stakeholder
concerns early, as they can influence public trust, with
serious public health consequences in the long term.
Methods
To monitor news in each country with planned vaccine
trials – Sierra Leone, Ghana, Uganda, and Kenya – the pro-
ject team selected online newspapers in each country. The
selection was based on a qualitative assessment of expected
impact and maximum variation to ensure detection of any
news regarding the planned trials. Services like Google
News Alert1 were considered for monitoring new articles
meeting specific criteria, but in several of the target coun-
tries the major search engines indexed only a few of these
news outlets, and these services were therefore not appro-
priate. Instead a PHP-based2 system was set up to monitor
the front page of the outlets for new articles every hour,
downloaded any new articles and scanned the articles for
variants of the keywords “Ebola” and “Vaccination”. The sys-
tem also forwarded all articles containing relevant keywords
to the Ebola vaccine program communication crisis team.
Using a thematic analysis [16] approach, three inde-
pendent coders (LL, WS, PEK) reviewed a subset of arti-
cles and were assigned to identify between 5 and 15
themes. Findings from a previous study [17] investigating
online vaccine sentiments were used as a starting point
for the codebook, which was further adapted to the Ghana
context. The team met to compare their proposed themes
and 24 were initially agreed upon, but after a change in
coders (ES, WS, PEK) an additional three themes were
added, for a total of 27 themes [see: Appendix 1].
Theme inclusion criteria were: a) they should be re-
peated in at least two different news outlets; and b) they
should be able to be reduced to declarative statements
about the trials or their proponents/opponents.
Two overarching types of themes were defined: (1)
“critiques” which directly or indirectly argue that the
trials should not take place, and (2) “rebuttals” refuting
the critiques, sometimes introducing new arguments in
favour of the trials.
Based on the codebook, a web-based coding interface
was developed allowing the coders to mark example text
and attach relevant coding tags to the text [see: Appendix
2]. When all coders had completed the first round of scor-
ing, the coders unanimously agreed on 87% of the coding
decisions. This gave an inter-rater reliability (IRR) score of
0.62, calculated using Fleiss’ kappa, which can be consid-
ered a high level of agreement [18]. The main reason for
calculating IRR here is to improve reliability. Inter-rater dis-
agreement can arise from actual disagreement, but when
dealing with large amounts of data, it is often based on mis-
reading or overlooking themes that are present.
In the second round, where one coder disagreed with the
other two, s/he was presented with the other raters’ coding,
accompanied by a relevant text extract from the article, and
asked whether s/he agreed. If s/he still disagreed it was sent
back to the others. This was repeated, and virtually all
discrepancies were reconciled. After two rounds of the
reconciliation process there were only five disagreements
left, giving an IRR which was very close to 1.0. In these
remaining five cases the coders agreed that the coding
decisions were fundamentally subjective [see: Appendix 3
for more details on the coding procedure].
Results
A total of 27,460 articles from nine different newspapers
were collected on-line from Ghana in the time period
from May 1st to July 30th 2015. Of these, 150 articles in
six different newspapers contained the keywords. Eleven
of the 150 articles were excluded because they referred
only indirectly to the trials, or not at all. The final data-
set included 139 articles (Fig. 1) [see: Appendix 3 for a
list of analysed articles].
The 139 reports analysed were collected from six news
outlets (Fig. 2) in which we identified 385 instances of
critiques and 279 instances of rebuttals.
Because the codebook specified more negative themes
than positive themes, no conclusions should be drawn
about overall ratio of positive versus negative sentiment. In-
stead, we gain insights by tracking groups of related themes
over time, how they evolved, identifying which critiques
were more prevalent, and which rebuttals were issued in
response. There were three key areas of critique: (1) the
allegation that the trials were secret; (2) the belief that the
trials would lead, in one way or another, to Ebola cases in
Ghana; and (3) the argument that the trials were providing
inappropriate incentive packages for participants.
Figure 3 shows the major organisations, listed in order
from most-mentioned to least-mentioned, referenced in
the media reports about the trials. Blue bars indicate the
number of articles mentioning a given organisation shown
MAJOR ONLINE NEWSPAPERS (n=9) SELECTED 
FOR SCANNING ARTICLES (n=27 460)
ARTICLES DOWNLOADED AND STORED
(n=27 460)
ARTICLES CONTAINING VARIANTS OF THE 
KEYWORDS “EBOLA” AND “VACCINE” (n=150)
EXCLUDED FOR NOT CONTAINING KEYWORDS 
“EBOLA” AND “VACCINE” (n=27 310)
EXCLUDED FOR NOT CONTAINING DIRECT 
REFERENCE TO THE TRIALS (n=11)
ANALYSED ARTICLES
(N=139)
Fig. 1 Study design flow chart. Flow chart shows data sources and
exclusion by keyword search and thematic analysis
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against grey background bars representing the total num-
ber of included articles published on a given day. The
Ghana FDA was named in the very first articles in mid-
May and remained a key actor throughout the debate,
whereas the Ministry of Health and World Health
Organisation (WHO) became more involved in mid-June.
Early and ardent critics of the trials, such as the Coalition
for Ghana’s Independence Now (CGIN) and the National
Democratic Congress (NDC), were most involved in early
June, whereafter their salience faded. Meanwhile the
Ghana Academy of Arts and Sciences (GAAS) maintained
a low but persistent media presence through to early July.
Figure 4 shows the prevalence of positive and negative
themes over time. The first article in our dataset was pub-
lished 21 May 2015 by Starr FM Online, the website for the
Ghanaian radio station Starr FM. This article broke the
story, presented as an “undercover” investigation into a se-
cret trial, which remained a common theme throughout the
controversy (see section "Secret trial and insufficient public
information"). It also drew attention to the incentives of-
fered for participation in the trial, which likewise remained
relevant for many weeks (see section "Incentives").
The story went seemingly unnoticed for more than a
week, until a press release was issued by the CGIN.3 The
statement (see Additional file 1), first published by Starr
FM Online (30.05), claimed that the trial researchers
would infect healthy Ghanaians with Ebola in order to
test the vaccine (see section "The fear that vaccine trials
will bring Ebola").
The story received increasing coverage over the fol-
lowing week, until the Volta regional office of the NDC
political party issued a statement opposing the trials,
which was then raised in Parliament. At this point,
critiques spiked dramatically, and rebuttals followed.
As shown in Fig. 5, a variety of themes were promin-
ent in the ensuing weeks, including arguments that the
trials were “unnecessary” because Ghana was unaffected
by the Ebola outbreak, that other diseases were more
important (Starr FM Online, 08.06a), and that the trials
should be conducted in a country other than Ghana.
Rebuttals tended to be broader statements, making the
case that the risk to participants was small and that
there had been no deviation from established protocols
(GhanaWeb, 08.06a), emphasising the global importance
of developing an Ebola vaccine (GhanaWeb, 08.06a), and
also that Ghana had an interest in the publicity and eco-
nomic benefits of hosting such research (Modern Ghana,
16.06b). They also pointed out that the vaccines had
already undergone some safety checks as they had been
tested in other countries (GhanaWeb, 08.07).
The issue of “ignorance” emerged in a prolonged back-
and-forth between Professor Alex Dodoo and the Ghanaian
Parliament, during which Dodoo was summoned to explain
his alleged criticism of Members of Parliament (MPs) as
“ignorant” regarding the procedures of clinical trials.4
While this prompted considerable reaction, most of the
related articles were as much about Parliament itself as
they were about Professor Dodoo’s comments.
A chronological overview of the major events can be
found in Appendix 1. To give a visual summary of the
coded data, a timeline of theme density is shown in Fig. 6.
Discussion
Secret trial and insufficient public information
Secrecy was a strong and recurrent theme (Fig. 6a), and
29 (21%) of 139 articles contained statements about the
trials being a secret. The initial Starr FM Online article
of 21 May included the passage, “Investigations by Starr
FM under-cover team have made public a clandestine
attempt by authorities to use midwifery students at
Hohoe in the Volta region for human experiment on the
Ebola vaccine in a country with no Ebola case.” The
CGIN press release brought greater attention to this
article, and this specific passage is repeated in a total of
19 articles up until 8 June.
Descriptions of the trials as “secret” or “clandestine”
were most prevalent in the first half of the controversy,
but following Parliamentary discussions, this theme was
superseded by the more restrained judgements that the
trials had provided “insufficient information” to politicians
NEWSPAPER NAME
TOTAL COUNT OF ARTICLES INCLUDED IN ANALYSIS
GHANAIAN CHRONICLE GHANAIAN TIMES GHANAWEB MODERN GHANA STARR FM ONLINE VIBEGHANA (TV)
124
140
104
121
29
56
13
14
32
22
9
4 6 62 44 20 4
CRITIQUE
REBUTTAL
Fig. 2 Overall count of articles included from each publisher, with theme proportions. Diagrams show the proportion of negative and positive themes
(critiques and rebuttals) in articles from each publisher, with size scaled to represent the number of articles included from each news outlet
(shown also in tabular form beneath)
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and had failed to “sensitise” the general public. Trial repre-
sentatives began responding in mid-June that information
had been provided and sensitisation would be done.
This softer criticism, that the trials had provided “in-
sufficient information,” appeared in 39 (28%) of the
articles. In an article titled, “House orders ‘secret’ Ebola
vaccination stopped,” MPs’ objections focused on a lack
of consultation with politicians and the general public:
“(…) the Deputy Minister of Education, Samuel
Okudzeto Ablakwa, said it was unacceptable for
the ministry to carry out such a sensitive exercise
without proper communication and sensitisation.
He said the exercise (…) did not have political
approval from the government, and appealed to
his colleagues not to put the blame on the
government.” (Ghanaian Times, 11.06).
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MENTION
COUNT ARTICLES MENTIONING ORGANISATION OVER TIME
ORGANISATION
DESCRIPTION
13
16
19
25
26
31
55
66
76
GHANA FOOD AND DRUGS 
AUTHORITY
GOVERNMENT AGENCY
REGULATING DRUGS
GHANA MINISTRY
OF HEALTH
GOVERNMENT AGENCY FOR
PUBLIC HEALTH IN GHANA
WORLD HEALTH
ORGANIZATION (WHO)
GLOBAL PUBLIC
HEALTH INSTITUTION
NATIONAL DEMOCRATIC 
CONGRESS (NDC)
POLITICAL PARTY WITH MAJORITY IN 
PARLIAMENT
UNIVERSITY OF HEALTH AND 
ALLIED SCIENCES (UHAS)
GHANAIAN UNIVERSITY LEADING 
VACCINE TRIALS
GHANA ACADEMY OF ARTS
AND SCIENCES (GAAS)
HONORARY, NON-EDUCATIONAL 
ACADEMIC SOCIETY
COALITION FOR GHANA 
INDEPENDENCE NOW (CGIN)
ACCRA-BASED
ACTIVIST GROUP
VOLTA
REGIONAL OFFICE
NDC PARTY’S RESPRESENTATIVES 
FOR THE VOLTA REGION
NEW PATRIOTIC
PARTY (NPP)
POLITICAL PARTY WITH LARGE 
MINORITY IN PARLIAMENT
MONDAY
25 MAY
THURSDAY
21 MAY
MONDAY
1 JUNE
MONDAY
8 JUNE
MONDAY
15 JUNE
MONDAY
22 JUNE
MONDAY
29 JUNE
MONDAY
6 JULY
MONDAY
13 JULY
MONDAY
20 JULY
Fig. 3 Daily count of stakeholder mentions. Number of articles mentioning institutional stakeholders daily (blue bars), compared to total relevant
articles daily (grey bars). Quantified by keyword search, conducted after completion of thematic analysis
Kummervold et al. BMC Public Health  (2017) 17:642 Page 5 of 24
Speaking before Parliament, Health Minister Alex
Segbefia struck a contrite tone, admitting the need for bet-
ter public engagement but asserting that approval had been
sought from all the appropriate institutions:
“He said standard protocol had been followed
prior to the approval for the vaccination to take
place, but he conceded that despite the rigorous
nature of the approval process, the stakeholder
consultation that needed to have been done was
not thorough enough.” (GhanaWeb, 16.06a).
In an interview published the following day, however,
Susan Adu Amankwah (a researcher unaffiliated with
either trial) ridiculed parliamentarians’ expectation of
being personally consulted:
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“The protocol of the trial had gone through the FDA …
[in accordance with] the law that they [MPs] themselves
passed – the Public Act 815 so the government knew
about it. If the government is not represented by the
FDA, if the state is not represented by the FDA, then I
don’t know who the FDA is.” (GhanaWeb, 17.06b).
Even as new public education efforts got underway,
the secrecy claim continued to reappear, such as
when the NPP party Ashanti Regional Chairman used
it to direct blame at Ghana’s president,
“… wondering how government, under the
leadership of President John Dramani Mahama,
could allow such an exercise to be conducted in
his homeland, without the necessary education and
approval.” (Ghanaian Chronicle, 22.06b).
In an article titled “When Scientists Become Too
Secretive,” author Cameron Duodo was clearly uncon-
vinced by the legalistic argument that the trials had
received proper approval:
“… scientists of the Ghana Food and Drugs Authority
(FDA) blithely authorised Ghanaian scientists, working
for a foreign pharmaceutical company to carry out
trials of an Ebola vaccine, without so much as a word
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Fig. 6 Daily count of individual themes, shaded by number of articles per day mentioning a given theme. Themes were conceived as “statements about
the trials,” and divided into two categories: critiques of the trials (red) and rebuttals on behalf of the trials (green). a Themes discussed in section "Secret trial
and insufficient public information": Descriptions of the trials as “secret” or “clandestine” were most prevalent in the first half of the controversy, but
following Parliamentary discussions, this theme was superseded by the more restrained judgements that the trials had provided “insufficient information”
to politicians and had failed to “sensitise” the general public. Trial representatives began responding in mid-June that information had been provided and
public sensitisation would be done. b Themes discussed in section "The fear that vaccine trials will bring Ebola": Early concerns about the trials’ safety in-
cluded two related but distinct fears – first, that trial participants might contract Ebola from the vaccine, and second, that because Ghana had no Ebola
cases, the researchers must have intended to introduce Ebola into the population for the purpose of testing the vaccines. Rebuttals included repeated ex-
planations of why the trial vaccines could not infect participants, as well as several assurances that Ebola was not being introduced to the country, however
most rebuttals focused more on the idea that the trials were “following all protocols” and safe in a general sense. c Themes discussed in section "Incen-
tives": Incentives – 200 Ghanaian Cedis (GH₵) and a mobile phone – were a target for extensive criticism, both from those who felt these were valuable
enough to be coercive, and also from those who perceived the trials to be very risky and consequently viewed the incentives as insultingly small. Rebuttals
included the clarification that phones were intended to facilitate communication between researchers and participants, and the money was to compen-
sate participants for their time. d Uncategorised themes
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to the Ghanaian public, to prepare their minds for the
trials.” (Ghanaian Times, 30.06).
This narrative of an immoral experiment lent itself to
historical comparisons, including the Tuskegee Syphilis
Experiment (Modern Ghana 08.06), its Guatemalan
counterpart (Ghanaian Chronicle, 25.06), and medical
crimes perpetrated under the racist regimes of Nazi
Germany and Apartheid South Africa (Ghanaian Times,
30.06). While such references were relatively sparse,
Ghana’s colonial past is a recurring theme throughout
the debate, particularly in the “incentives” issue.
Lastly, long after the peak of the debate, a key trad-
itional leader in the Hohoe region professed his long-
standing support for the trials, and his bemusement at
the national controversy:
“The Paramount Chief of Gbi Traditional Area,
Togbe Gabusu, … wondered why the Ebola vaccine
trial should generate so much controversy. “I have
never doubted this because when they [researchers]
came, they called all the traditional heads. They met
us talked to us and we were satisfied before the
hullabaloo came. We have a Research Centre in town
here, it has been here for [many] years…and they have
been working. So why this?”, the Paramount Chief
wondered.” (Modern Ghana, 17.07).
The idea that the trials were “secret” was initially
propagated by the Starr FM Online article, in which
local students described being approached about
participating in an upcoming trial, and in which in-
terviewees affiliated with the UHAS research centre
“pleaded anonymity,” and insisted they “could not
disclose” information. It seems likely that the inter-
viewees were attempting to adhere to perfectly or-
dinary non-disclosure agreements, considering that
the trials were still under review. This may have
added an unintentionally conspiratorial air to their
comments.
The Starr FM Online article also instigated the idea of
secrecy by the mere fact that it was the first place where
the trials were widely publicised. In the words of
commentator Cameron Duodu,
“if you … try, even if metaphorically, to “smuggle” the
project into the country, you will ensure that the first
that is heard of it is through the news broadcast by a
local radio station, then you are asking for trouble”
(Ghanaian Times, 30.06).
The mere fact that the public was not aware of the tri-
als lent credibility to the claims in the Starr FM Online
article. Then again, the trials were forbidden to conduct
any public education prior to receiving ethics approval,
so its absence was not so much a mistake, but rather a
vulnerability inherent in the established protocol for
conducting research, which may need to be revised.
The fear that vaccine trials will bring Ebola
One of the most common critiques was that the vaccine
trials would lead to Ebola cases in Ghana. Out of 139
articles in our dataset, 47 (33%) claimed that the vaccine
would cause an Ebola outbreak in Ghana, while 27 arti-
cles (19%) said this would not happen. The critique
came in two distinct forms: first, a suspicion that trial
researchers would intentionally expose people to Ebola
virus in order to test the vaccine, and second, a fear that
the vaccine itself would cause participants to contract
Ebola. Rebuttals included direct responses to both of
these critiques, and overarching statements that the tri-
als were safe and protocols had been followed. Figure 6b
shows when each of the critiques appears, and when
each is countered.
The claim is first mentioned in Starr FM Online
(30.05), and is a direct quote from a press release issued
by CGIN:
“Ebola outbreak, which is 100% sure to happen in
Ghana should this human trials be allowed to go on,
will be the greatest national security threat our
country will ever face. The manufacturers of the so-
called Ebola vaccine will look on till a larger number
of Ghanaians are killed by the disease here in Ghana
before the vaccine will be released and this would hap-
pen to make government buy the vaccine at any
price…there is and will be no way by which Ghana
can go through this Ebola virus human experiment
without Ebola being spread country wide.” (Starr FM
Online, 30.05).
Thus the original claim was that Ebola had to be intro-
duced to be able to test the vaccine. After a fierce
debate, in which the CGIN statement was referenced in
the majority of the monitored newspapers, the first
statements defending the trials found their way into the
media more than a week later:
“The Food and Drugs Authority (FDA) has refuted
claims that the impending Ebola vaccine trial in
Ghana will harm persons who will be used as subjects
for the exercise. ”(Starr FM Online, 08.06).
“According to FDA documents, the vaccines to be
tested in Ghana are made using a common cold virus
called an adenovirus that “does not make people sick”.
The vaccines contain extracts that do not cause the
disease from the Ebola virus.” (GhanaWeb, 09.06).
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After the trials were suspended by the Minister of
Health on 9 June (after being ordered to do so by Parlia-
ment) the debate continued and the GAAS issued a
press statement on 12 June stating that it was “unsafe to
undertake the trials in Ghana”. The statement included a
list of ten technical questions, including:
“What assurances do we have that the chimpanzee-
derived live adenovirus vector used in the GSK vaccine
construct, although non-replicating for now, will re-
main dormant and not itself cause a disease to com-
promise the health of the people of Ghana?”
(GhanaWeb, 15.06a).
Several writers demanded that “The World Health
Organization Must Respond to the Queries of the
Ghana Academy of Arts and Sciences,” (GhanaWeb,
27.06). On 26 June UHAS issued a press statement
[19] rebutting the scientific questions point-by-point.
Principal Investigator Professor Fred Binka also gave
rebuttals in person at a sensitisation forum, and of-
fered to undergo vaccination himself (Modern Ghana,
22.06). However, newspapers continued re-printing
the GAAS critiques as late as 5 July, without acknow-
ledging these rebuttals. Only one article reported on
the UHAS response, and not until 8 July.
Moreover, the GAAS was portrayed as a mouthpiece
of the people: “Ghanaians, through the Ghana Academy
of Arts and Sciences (GAAS), have posed Ten Queries
which WHO is required to take extremely seriously and
reply to.” (GhanaWeb, 27.06), in contrast to portrayals
of the Ghana FDA as “…a body grandiosely semi-
labelling itself after an illustrious American name
sake…” (GhanaWeb, 15.06).
So, it appears that the initial fear about scientists
intentionally introducing Ebola was gradually replaced by
the concern that the vaccine itself could cause disease,
and this narrative became somewhat more scientifically
sophisticated after the GAAS’ list of questions became a
focal point. There were other passages, such as “The Ho
West MP added that MPs from the region have been inun-
dated with phone calls from panic-stricken constituents
who believe that this trial is aimed at spreading the
dreaded Ebola disease in the Volta Region. ”(GhanaWeb,
15.06b), that indicate a perception that people would be
infected prior to vaccination. However, most quotes be-
tween 16-22 June are related to whether the adenovirus
vector might mutate into a virulent form of the Ebola
virus and infect trial participants.
Incentives
The debate around incentives was challenging to respond
to: most complained that the incentives for trial participa-
tion were insufficient, but others simultaneously claimed
they were inappropriately large, and in general the allega-
tions made no distinction between the GSK trial (which
was to offer participants money and a mobile phone) and
the Janssen trial (which was not). The incentives were per-
ceived as compensation for the trial’s dangers (as opposed
to compensation for the cost of travel and time lost), and
these dangers were thought to be great, leading to the
conclusion that the incentives were too little. There were
far fewer concerns about the incentives being coercively
large compared with the many allegations that they were
insultingly paltry. The claim that these incentives violated
international standards for participant compensation, in
some places attributed to WHO (see for instance Ghana-
Web, 10.06d), added to the sense of insult. Rebuttals were
issued to the effect that the incentives were for practical
purposes (money for transport and phones for follow-up
communication), but it is evident that the density of these
rebuttals was sparser than that of the critiques.
The “incentives” theme appeared early in the debate
peaking in the month of June (see Fig. 6c). It is one of
the most frequent themes, with 49 of 139 articles (35%)
mentioning it, and received relatively few rebuttals.
Incentives – 200 Ghanaian Cedis (GH₵)5 and a mobile
phone – were a target for extensive criticism, both from
those who felt these were valuable enough to be coer-
cive, and also from those who perceived the trials to be
very risky and consequently viewed the incentives as in-
sultingly small. Rebuttals included the clarification that
phones were intended to facilitate communication be-
tween researchers and participants, and the money was
to compensate participants for their time and transport.
As with secrecy, the topic of incentives is central in
the initial Starr FM Online article:
“Documents cited by Starrfmonline.com indicate that
the students have been promised [GH₵] 200 each and
mobile phones.” They will also receive other
compensations (…) “I’m really scared and a lot of my
colleagues are apprehensive too,” a student confided in
Starrfmonline.com. “Currently, they are compiling our
names for the trial but we don’t know whether the
vaccine is safe or not; whether we’ll contract the
disease or otherwise. Nobody is explaining anything to
us.” (Starr FM Online, 21.05).
The incentives are described neutrally, yet appear along-
side fearful quotes. Similar references appeared in late
May and early June, until the Volta office of the NDC
party released a statement condemning the trials and
portraying the incentives in a decidedly negative light:
“We are appealing to all Voltarians to remain calm
and should not risk their lives for [GH₵] 200 and
mobile phone,” a statement signed by the NDC
Kummervold et al. BMC Public Health  (2017) 17:642 Page 9 of 24
regional chairman Kwadwo Gyapong, secretary Simon
Amegashie-Viglo and regional organiser Henry Kojo
Ametefee said. (Starr FM Online, 08.06a).
In an opinion piece published the following day, writer
Michael Bokor issued a strong condemnation:
“Clearly, using Ghanaians as guinea pigs for this
Ebola vaccine experiment is insulting and misguided.
It is unethical, immoral, and despicable, especially if
we consider what is being used as an inducement for
participants.” (Modern Ghana, 09.06b).
Not all articles were so critical, and at least one correctly
reported that the phone was provided “to facilitate com-
munication and monitoring” (Modern Ghana, 10.06c).
When the issue was brought before Parliament, however,
the Majority Chief Whip proposed “to invite the foreign
pharmaceutical companies to do some explanations, be-
cause entering into a community and using mobile phones
and [GHC] 200 to entice people for such a dangerous re-
search is simply unacceptable.” (Ghanaian Times, 11.06).
Harsh opinion articles followed, arguing both that “volun-
teers in other countries will not take less than US$2,000 or
£1,000 per a single trial, in Ghana volunteers are being of-
fered £40 ([GHC] 200) plus a cheap or substandard mobile
(cell) phone likely to be of Chinese-made” (Modern Ghana,
12.06b), and also that that the incentives were coercively
high and that participants:“… should not be influenced in
their decision by psychological or financial pressures of any
sort.” (Ghanaian Times, 16.06).
These contradictory criticisms presented an obvious
challenge for defending the incentives. Early rebuttals
focused on the practicality of the incentives:
“…the [GHC] 200.00 was supposed to cater for the
transportation of the volunteers while the mobile
phone was to help health personnel assess the health
of the volunteers once the vaccine has been
administered on them.” (Modern Ghana, 10.06b).
WHO country representative for Ghana Dr. Magda
Rabalo managed to address the issue of the amount pro-
vided in the incentive package during a forum in Accra:
“…the ethics committee of trials said such moneys
should not be too much or too little to manipulate
people to volunteer… It also noted that WHO does not
define how much participant should be paid and that
compensations differ from country to country.”
(Vibeghana (TV), 20.06).
Finally, several weeks later, an interview with Dr. Ama
Kyerewaa Edwin, member of the Ghana Health Service
Ethics Committee, clarified the actual compensation
being given:
“... [participants] are not paid for volunteering but you
will be compensated for your time and traveling in and
out of the research Centre. … Persons who offer
themselves for the Ebola vaccine trial in Ghana will be
given a comprehensive international insurance cover
against any unintended consequences,” (Starr FM
Online, 08.07).
Limitations
This analysis only looks at English-language online media
in a lower-middle-income country. It does not include
print-only publications, radio or television broadcasts, and
is therefore only analysing a subset of the media. However,
we find few, if any, references in the online material to
print-only sources.
In using these data to study a public debate, we as-
sume that the timing and quantity of news coverage
around a specific theme reflects the salience of that
theme in the public consciousness. However, topics re-
ported also reflect other factors, like editorial bias and
preference for sensational stories.
As noted in the Results section, we make no attempt
to draw conclusions from the aggregate amount of posi-
tive and negative themes observed in the dataset. A
weighted analysis might account for the different num-
ber of positive and negative themes defined in the code-
book. However, this would mask the fact that the
themes do not measure discrete units of “positivity” and
“negativity” but rather points and counterpoints in a
narrative, which don’t combine additively. This may be
an interesting subject for future research, nonetheless.
In our study we assume all articles to have equal influence.
If the dataset were larger, it would be reasonable to attribute
a weight based on the number of readers or geographic
reach of a publication to estimate their potential influence.
Our analysis is based on manually coding themes. All
coding was done using online tools, annotating the live
data directly. Compared to traditional qualitative analysis,
it is effective. However, it still means all articles matching
specific keywords need to be read manually. Advance-
ments in machine learning approaches might make it pos-
sible in the future to develop tools that will automate part
of the coding in order to better provide real time monitor-
ing to help health communication teams.
Conclusion
The rumours identified in this dataset highlight the vital
importance of understanding the emotional context of
public concerns: a story of secret vaccine trials in Ghana,
or scientists intentionally infecting Ghanaians with Ebola,
is only credible in the context of deep mistrust. Indeed,
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the trials debate is marked, from beginning to end, by the
overwhelming fear engendered by the Ebola outbreak, as
well as a pervasive anxiety to distance Ghana from the
disease, even at the expense of research that could help
protect against it. Since the trials themselves were partly
sponsored by Western pharmaceutical companies, oppos-
ing them could be portrayed as a show of independence
from the influence of former colonial powers. In this way,
critics tapped into long-running historical themes, as well
as the visceral fear of the Ebola epidemic.
By analysing the debate from its inception, we can
track the evolution of issues from their initial appear-
ance in alarming news articles, to examples of extreme
claims becoming more sober, as seen in the transition
from claims of a “secret trial” towards more moderate
complaints that too little sensitisation and stakeholder
consultation had been done. As early opponents like the
CGIN dropped out of the news, attention focused on
high-profile figures, and in this process, these public
figures may have felt that they needed to justify their ini-
tial position to avoid embarrassment. This could explain
the overall increase in the sophistication of arguments
against the trials, while the initial emotions remained at
the heart of the debate. As shown in this analysis, even
marginal critics can mobilize a widespread and sophisti-
cated opposition movement to derail important public
health programmes, if they are taken up by high-profile
opinion leaders. The situation in Ghana demonstrates
the importance of early and constant engagement with
both supporters and critics of trials, bringing them into
conversations and ensuring that their fears, concerns
and perspectives are heard and considered from the very
beginning of the process. We recommend early engage-
ment as a way to minimise the risk of individuals and
communities feeling excluded, or their concerns dis-
missed, provoking perceptions of secrecy and potentially
leading high-profile opinion leaders to take up their
arguments on a wider scale.
It is noteworthy that although some of the initial
critiques remained major themes throughout the debate,
others, such as the conspiratorial allegation that “Ebola
is a business,” did not last as long. Not unlike an infec-
tious disease outbreak, beginning with an isolated index
case and followed by a larger flare-up, some strains of
these rumours proved more contagious than others.
New arguments and angles also emerged as more people
joined the debate. For example, the controversy clearly
resonated with racial and colonial themes, as evidenced
by the repeated references to historical instances of un-
ethical experimentation on African bodies. This should
serve as a stark reminder that past injustices can still
undermine trust in the present. In addition, researchers
should work to build trusting relationships within the
communities where they are working by being
consistently open and transparent as early as possible.
This is particularly vital when considering sensitive is-
sues or protocol requirements such as taking blood or
the use of incentives that may be particularly sensitive
given histories of extraction in the region.
Although regulations sometimes prevent trials from
sharing public information about a specific trial prior to
receiving ethical approval, this doesn’t necessarily pre-
clude the possibility of a more general, government-led
national discussion on the need for an Ebola vaccine, the
strong value that such a vaccine would have for Ghana’s
national security, and the long-term economic and dip-
lomatic benefits of taking part in the international effort.
Such a generalised national dialogue - avoiding the
specifics of any one candidate vaccine trial - should be
considered, especially when the disease in question is so
emotionally fraught, and so relevant to the whole nation.
We also recommend the involvement of community
representatives in the development of clinical trial proto-
cols, in order to ensure that trial designs are both scien-
tifically valid and also acceptable to the communities
within which they are occurring.
One of the other major challenges is making the col-
lected information comprehensible and useable to deci-
sion makers. To achieve this, effective visualisation
techniques are vital. Some of these techniques are dem-
onstrated in this article, and many of these can be gener-
ated on-demand in real time. For stakeholders involved
in a major health crisis, real-time insights can be vital,
given the limited amount of time available for decision-
making. It is our hope that these techniques can be in-
corporated into a reliable tool for assessing public infor-
mation needs in future epidemics and similarly emotive
national crises.
Endnotes
1https://www.google.com/alerts
2PHP (PHP: Hypertext Preprocessor) is an open
source general-purpose scripting language that is espe-
cially suited for web development. https://www.php.net
3The document in question was written by Tawiah
Evans, a former journalism student who operates the
CGIN with a number of other activists based in Accra.
4“Prof Dodoo, on the airwaves, had described MPs as
ignorant for making misleading and unfounded comments
on the Ebola vaccine trial in the country following MPs’
opposition to the vaccine trial.” (Modern Ghana,17.06c)
5200GH₵ is the equivalent of approximately 48USD/
44EUR. According to the World Bank, the minimum
monthly wage for a 19-year old or apprentice in Ghana
was around 28USD (118GH₵) in 2013 (https://web.arch-
ive.org/web/20170728085136/http://datatopics.world-
bank.org/jobs/country/ghana)
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Table 1 Final coding guidelines
Theme Description Type
Secret trial Anything that indicates that the trial is/was secret. NEG
No approval The trial lacks approval from a public authority. NEG
Inappropriate incentives The incentives for trial participants are mentioned as a problem. NEG
Insufficient trial information The trial ought to have declared itself to / done more outreach and
sensitisation with participants/general public/local leaders/national
leaders. Having gotten approval without informing goes into this
category
NEG
Corporate conspiracy The Ebola/vaccine/trial being done for business. NEG
Introduction of Ebola before vaccine Any claim that the trial will give people Ebola first, to be able to test the vaccine NEG
Risk of Ebola after vaccine People will get Ebola from the vaccine NEG
Safety and side effects Any side effects and safety concerns NEG
Past violations of medical ethics The trial is similar to historical examples of unethical medical practice/experiments NEG
Sterilisation/population control The trial is part of a conspiracy to sterilise people / control the population NEG
Other diseases more important Addressing other health issues (e.g. cholera) more important than conducting the trial. NEG
Not in Ghana Thinks it should be done, but in another place, for reasons including: NIMBY/
county/town/region/ethnic group, doesn't make sense because Ghana is Ebola-free
NEG
Guinea Pig Any description of trial participants as Guinea Pigs. NEG
Animals first The vaccine hasn’t been tested on animals yet. NEG
Trials are unnecessary The trial is unnecessary/needless (e.g. because Ghana is Ebola-free) NEG
Religion The trial should not be done because “we prayed and God spared us” from Ebola NEG
No introduction of Ebola before vaccine We don’t have to give people Ebola to test the vaccine POS
No risk of Ebola after vaccine People will not get Ebola from the vaccine POS
Protocols followed Responses that say ethical, legal requirements have been met
(which presumes public trust in the FDA, in the regulations and their enforcement).
Excellent example of the difference between what ethics means to a researcher vs.
a layperson.
POS
Vaccine important Helping develop the vaccine is an ethical imperative in itself POS
Ghana benefits from the trials Participating the trials is in Ghana’s self interest since it will develop scientific and
business capacity/reputation, and/or having the vaccine will help Ghana prepare
for another outbreak
POS
Tested elsewhere Other countries have tested the vaccine/are also testing it, which should reassure/
inspire Ghana to participate as well
POS
Sufficient trial information given We are doing/have done/ will do all the necessary and appropriate informing and
sensitizing and outreach
POS
Ignorant opponents People opposing the vaccine are ignorant etc. Including general characterisation of
people opposing trial
POS
Appropriate Incentives Money and phone are for practical purposes of transport and communication, not
an undue incentive
POS
Trials are safe overall The trial is safe (this code applies to all safety/side effect reassurances except those
focusing on the fear of getting Ebola, which were coded as Not Ebola first/after)
POS
Ebola-free setting useful for testing vaccines The test must be done in Ghana because it is an Ebola-free country POS
Appendix 1
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Appendix 2
Procedure for coding and resolving disagreements
The following procedure were followed for each
article after initial coding:
 A theme that all coders included was marked as
“present”.
 A theme none of the coders included was marked as
“not present”.
 A theme Coder 1 marked but not Coder 2
or Coder 3 was marked as “Challenge for Coder 1”.
○ [Repeated for Coder 2 and Coder 3]
 A theme Coder 2 and Coder 3 marked but
not Coder 1 was marked as “Challenge for Coder 1”.
○ [Repeated for Coder 2 and Coder 3]
After initial coding all themes in the article then
one of the following statuses:
 Theme is present
 Theme is not present
Table 2 Analysed articles and major incidents
Date Newspaper Url Archived url Title
21.05 This is the real start of the media debate. First article appears, but is not quoted by any other outlet until 10 days later
21.05 Starr FM
Online
http://www.starrfmonline.com/1.3920389 https://web.archive.org/web/
20150524021135/http://
starrfmonline.com/1.3920389
Ebola vaccine trial hits Hohoe; GH¢200,
phones for participants
29.05 CGIN posts press release. Press release included as Additional file 1.
30.05 Starr FM
Online
http://www.starrfmonline.com/1.4162568 https://web.archive.org/web/
20150602053125/http://
www.starrfmonline.com/1.4162568
Stop “criminal” Ebola vaccines trial in
Ghana - Coalition
31.05 GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=360308
https://web.archive.org/web/
20151025012812/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=360308
Stop “criminal” Ebola vaccines trial in
Ghana - Coalition
03.06 According to article in the BMJ (http://www.bmj.com/content/350/bmj.h2105/rr-7. Archived at: https://web.archive.org/web/
20170728081845/http://www.bmj.com/content/350/bmj.h2105/rr-7) there was a meeting with the health minister and NAAS/GAAS this day,
where NAAS presented a preliminary report
03.06 FDA holds emergency meeting
03.06 GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=360701
http://web.archive.org/web/
20150815232325/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=360701
FDA holds meeting on Ebola vaccination
trials
03.06 Modern
Ghana
http://www.modernghana.com/news/
621048/1/fda-holds-meeting-on-ebola-
vaccination-trials.html
http://web.archive.org/web/
20150809184735/http://
www.modernghana.com/news/621048/
1/fda-holds-meeting-on-ebola-
vaccination-trials.html
FDA holds meeting on Ebola vaccination
trials
07.06 NDC issues press release where they say no to Ebola trials in the Volta region.
08.06a Starr FM
Online
http://www.starrfmonline.com/1.4294638 http://web.archive.org/web/
20150611033541/http://
www.starrfmonline.com:80/1.4294638
NDC says no to “needless” Ebola
vaccines trial in Volta region
08.06a GhanaWeb http://web.archive.org/web/
20150816151139/http://
Ebola vaccine trial won’t harm Ghanaians
– FDA
 Challenge for Coder 1, Coder 2 or Coder3
Coder 1 was then presented with the following
choice:
 Coder 2 and Coder 3 marked this as theme X. They
based this on the following quotes. Do you agree or
disagree?
 Only you coded this as theme X. You did base it on the
following quote. Do you still agree?
 [Repeated for Coder 2 and Coder 3]
As long as the article was marked as a challenge, it
was hidden for the agreeing coders. In cases where
the challenge was not solved by agreement, it was
sent back to the other coders, and the process re-
peated. The majority coders would then see one of
message like:
 Coder 1 insists this should (not) be coded as theme
X. Do you agree?
Appendix 3
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Table 2 Analysed articles and major incidents (Continued)
http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=361484
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=361484
08.06 Modern
Ghana
http://www.modernghana.com/news/
621918/1/ndc-says-no-to-needless-ebola-
vaccines-trial-in-vr.html
http://web.archive.org/web/
20150810104450/http://
www.modernghana.com/news/621918/
1/ndc-says-no-to-needless-ebola-
vaccines-trial-in-vr.html
NDC Says No To Needless Ebola
Vaccines Trial In V/R
08.06b Starr FM
Online
http://www.starrfmonline.com/1.4322726 http://web.archive.org/web/
20150730025947/http://
www.starrfmonline.com/1.4322726
‘Ebola vaccine trial won’t harm
Ghanaians’ – FDA
08.06c Starr FM
Online
http://www.starrfmonline.com/1.4313070 http://web.archive.org/web/
20150730025658/http://
www.starrfmonline.com/1.4313070
Ebola vaccines trial: Scientists confused
over ‘Starter’ and ‘Booster’ drugs
08.06b GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=361405
http://web.archive.org/web/
20150816153837/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=361405
NDC says no to “needless” Ebola
vaccines trial in V/R
08.06 An FDA News release is issued, containing an approval of the trial. Mentioned in GhanaWeb on the 10th.
09.06 Vibeghana
(TV)
http://vibeghana.com/2015/06/09/no-
ghanaian-should-be-a-guinea-pig-for-
ebola-experiments/
http://web.archive.org/web/
20160126224127/http://vibeghana.com/
2015/06/09/no-ghanaian-should-be-a-
guinea-pig-for-ebola-experiments/
No Ghanaian should be a guinea pig for
Ebola experiments
09.06a Modern
Ghana
http://www.modernghana.com/news/
622229/1/students-paid-for-ebola-drugs-
trial.html
http://web.archive.org/web/
20150810143334/http://
www.modernghana.com/news/622229/
1/students-paid-for-ebola-drugs-trial.html
Students Paid For Ebola Drugs Trial
09.06b Modern
Ghana
http://www.modernghana.com/news/
622266/1/no-ghanaian-should-be-a-
guinea-pig-for-ebol.html
http://web.archive.org/web/
20150810143552/http://
www.modernghana.com/news/622266/
1/no-ghanaian-should-be-a-guinea-pig-
for-ebol.html
No Ghanaian should be a guinea pig for
Ebola experiments
09.06 GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=361643
http://web.archive.org/web/
20150816181512/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=361643
GSK, Johnson & Johnson behind Ebola
vaccine trial in Ghana
09.06 Minister of Health, Alex Segbefia, has directed that the Ebola vaccination trial to be held in the Volta Region be suspended.
10.06 Parliament discusses the Ebola trials. It is unclear whether the trials are suspended by the house, or if this really is Segbefia’s decision
10.06a GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=361848
http://web.archive.org/web/
20150817054520/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=361848
Ebola vaccine trial: FDA exposes Health
Ministry
10.06a Modern
Ghana
http://www.modernghana.com/news/
622549/1/govt-suspends-ebola-vaccine-
trial.html
http://web.archive.org/web/
20150810194735/http://
www.modernghana.com/news/622549/
1/govt-suspends-ebola-vaccine-trial.html
Govt Suspends Ebola Vaccine Trial
10.06b Modern
Ghana
http://www.modernghana.com/news/
622538/1/ebola-vaccine-trial-in-vr-
suspended.html
http://web.archive.org/web/
20150810194914/http://
www.modernghana.com/news/622538/
1/ebola-vaccine-trial-in-vr-
suspended.html
Ebola Vaccine trial in VR suspended
10.06c Modern
Ghana
http://www.modernghana.com/news/
622582/1/fda-gives-approval-for-ebola-
vaccine-clinical-tria.html
http://web.archive.org/web/
20150810182219/http://
www.modernghana.com/news/622582/
1/fda-gives-approval-for-ebola-vaccine-
clinical-tria.html
FDA gives approval for Ebola Vaccine
Clinical Trials
10.06b GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=361853
http://web.archive.org/web/
20150817034559/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=361853
Parliament orders for suspension of
Ebola Vaccine trial
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10.06c GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=361806
http://web.archive.org/web/
20150817062832/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=361806
Health Minister suspends Ebola vaccine
trial
10.06d GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=361789
http://web.archive.org/web/
20150817052606/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=361789
FDA okays Ebola for phone vaccine trial
10.06a Starr FM
Online
http://www.starrfmonline.com/1.4385506 http://web.archive.org/web/
20150730085150/http://
www.starrfmonline.com/1.4385506
Parliament summons health minister
over Ebola Vaccine trial
10.06e GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=361831
http://web.archive.org/web/
20150817033332/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=361831
Mahama’s incompetence makes me
regret criticizing Mills’
10.06d Modern
Ghana
http://www.modernghana.com/news/
622642/1/im-ready-for-ebola-vaccine-
trial-ndc-mp.html
http://web.archive.org/web/
20150810174618/http://
www.modernghana.com/news/622642/
1/im-ready-for-ebola-vaccine-trial-ndc-
mp.html
I’m ready for Ebola vaccine trial - NDC
MP
10.06b Starr FM
Online
http://www.starrfmonline.com/1.4384597 http://web.archive.org/web/
20150730101102/http://
www.starrfmonline.com/1.4384597
Relief at Hohoe Midwifery College as
gov’t suspends Ebola vaccine trial
10.06c Starr FM
Online
http://www.starrfmonline.com/1.4359741 http://web.archive.org/web/
20150730094225/http://
starrfmonline.com/1.4359741
Gov’t suspends Ebola vaccine trial
10.06 Modern
Ghana
http://www.modernghana.com/news/
622425/1/fda-okays-ebola-for-phone-
vaccine-trial.html
http://web.archive.org/web/
20150810194834/http://
www.modernghana.com/news/622425/
1/fda-okays-ebola-for-phone-vaccine-
trial.html
FDA Okays Ebola For Phone Vaccine Trial
11.06a GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=361978
http://web.archive.org/web/
20150817082252/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=361978
Mahama should take Ebola vaccine trials
to Bole – NPP Chair
11.06b GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=362043
http://web.archive.org/web/
20150817084202/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=362043
No need to entertain Ebola vacine trial –
Deputy Speaker
11.06 Starr FM
Online
http://www.starrfmonline.com/1.4391140 http://web.archive.org/web/
20150730122430/http://
www.starrfmonline.com/1.4391140
Take “cruel” Ebola trial to Bole; Be fair to
V/R - NPP reg chair to Mahama
11.06a Modern
Ghana
http://www.modernghana.com/news/
622700/1/mps-angry-over-ebola-for-
phone-trial.html
http://web.archive.org/web/
20150810213743/http://
www.modernghana.com/news/622700/
1/mps-angry-over-ebola-for-phone-
trial.html
MPs Angry Over Ebola For Phone Trial
11.06b Modern
Ghana
http://www.modernghana.com/news/
622811/1/ebola-vaccine-trial-could-
revolutionize-ghanas-eco.html
http://web.archive.org/web/
20150810221820/http://
www.modernghana.com/news/622811/
1/ebola-vaccine-trial-could-revolutionize-
ghanas-eco.html
Ebola vaccine trial could revolutionize
Ghana’s economy
11.06c Modern
Ghana
http://www.modernghana.com/news/
622801/1/no-to-ebola-vaccine.html
http://web.archive.org/web/
20150810213901/http://
www.modernghana.com/news/622801/
1/no-to-ebola-vaccine.html
No To Ebola Vaccine
11.06c GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=362036
http://web.archive.org/web/
20150817072107/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=362036
Rejection of Ebola Vaccine trial a sad day
for science – Prof. Dodoo
11.06
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Vibeghana
(TV)
http://vibeghana.com/2015/06/11/
parliament-calls-for-suspension-
stoppage-of-ebola-vaccine-trial/
http://web.archive.org/web/
20160127034105/http://vibeghana.com/
2015/06/11/parliament-calls-for-
suspension-stoppage-of-ebola-vaccine-
trial/
Parliament calls for suspension, stoppage
of Ebola vaccine trial
11.06d GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=361893
http://web.archive.org/web/
20150817074605/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=361893
Test Ebola vaccine on gov’t officials –
Lawyer
11.06d Modern
Ghana
http://www.modernghana.com/news/
622775/1/rejection-of-ebola-vaccine-trial-
a-sad-day-for-sci.html
http://web.archive.org/web/
20150810221743/http://
www.modernghana.com/news/622775/
1/rejection-of-ebola-vaccine-trial-a-sad-
day-for-sci.html
Rejection of Ebola Vaccine trial a sad day
for science - Prof. Dodoo
11.06e GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=362064
http://web.archive.org/web/
20150817085500/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=362064
Shut up! – Prof Dodoo tells MPs, others
11.06f GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=361872
http://web.archive.org/web/
20150817083518/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=361872
I’m ready for Ebola vaccine trial - NDC
MP
11.06 Ghanaian
Times
http://www.ghanaiantimes.com.gh/
house-orders-secret-ebola-vaccination-
stopped/
http://web.archive.org/web/
20170727181709/http://
www.ghanaiantimes.com.gh/house-
orders-secret-ebola-vaccination-stopped/
House orders ‘secret’ Ebola vaccination
stopped - The Ghanaian Times
11.06 g GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=361895
http://web.archive.org/web/
20150613192335/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=361895
Gov’t donating Ghanaians to the
slaughter house – Atik
11.06 h GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/features/
artikel.php?ID=361775
http://web.archive.org/web/
20150817065704/http://
www.ghanaweb.com/GhanaHomePage/
features/artikel.php?ID=361775
No Ghanaian should be a guinea pig for
Ebola experiments
12.06 NAAS/GAAS posts press statement (http://citifmonline.com/2015/06/12/govt-was-warned-against-ebola-vaccine-trial-academy-of-arts-and-
sciences/#sthash.2j4TiUiG.dpbs. Archived at: https://web.archive.org/web/20150614005137/http://citifmonline.com/2015/06/12/govt-was-
warned-against-ebola-vaccine-trial-academy-of-arts-and-sciences/)
12.06a Modern
Ghana
http://www.modernghana.com/news/
622919/1/where-are-the-cholera-
vaccines.html
http://web.archive.org/web/
20150811000029/http://
www.modernghana.com/news/622919/
1/where-are-the-cholera-vaccines.html
Where Are The Cholera Vaccines?
12.06a GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=362084
http://web.archive.org/web/
20150817114033/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=362084
Noguchi damns Parliament over Ebola
vaccine trial
12.06b GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/entertainment/
artikel.php?ID=362193
http://web.archive.org/web/
20150817100255/http://
www.ghanaweb.com/GhanaHomePage/
entertainment/artikel.php?ID=362193
Ebola Vaccine trial: Afia Schwarzenegger
blasts FDA
12.06b Modern
Ghana
http://www.modernghana.com/news/
622929/1/ghanaians-to-beware-of-the-
gove.html
http://web.archive.org/web/
20150811012317/http://
www.modernghana.com/news/622929/
1/ghanaians-to-beware-of-the-gove.html
Ghanaians To Beware Of The
Governmental Ebola Vaccine Trials
13.06a GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/features/
artikel.php?ID=362264
http://web.archive.org/web/
20150919105802/http://
www.ghanaweb.com/GhanaHomePage/
features/artikel.php?ID=362264
Ghanaians must be happy to be part of
ebola vaccine trial.
13.06 Modern
Ghana
http://www.modernghana.com/news/
623134/1/may-be-ghanaians-are-ready-
for.html
http://web.archive.org/web/
20150811035520/http://
www.modernghana.com/news/623134/
1/may-be-ghanaians-are-ready-for.html
May Be, Ghanaians Are Ready For Mass
Immunization Of An Ebola Vaccine That
Was Never Tried On Humans
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13.06b GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/features/
artikel.php?ID=362263
http://web.archive.org/web/
20150817130218/http://
www.ghanaweb.com/GhanaHomePage/
features/artikel.php?ID=362263
Ghanaians to Beware of the
Governmental “Ebola Vaccine Trials”
15.06a GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/features/
artikel.php?ID=362631
http://web.archive.org/web/
20150818000541/http://
www.ghanaweb.com/GhanaHomePage/
features/artikel.php?ID=362631
Monkeying around with an Ebola
vaccine
15.06b GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=362622
http://web.archive.org/web/
20150818014800/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=362622
Health Minister hot over Ebola Vaccine
trial deal
15.06c GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=362512
http://web.archive.org/web/
20150818015006/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=362512
Noguchi boss criticises suspension of
Ebola vaccine trials
15.06 Modern
Ghana
http://www.modernghana.com/news/
623582/1/we-are-not-guinea-pigs-.html
http://web.archive.org/web/
20150811105954/http://
www.modernghana.com/news/623582/
1/we-are-not-guinea-pigs-.html
We Are Not Guinea Pigs!
16.06 Parliament discusses the Ebola trials
16.06a Modern
Ghana
http://www.modernghana.com/news/
623885/1/ebola-vaccine-trial-in-ghana-
will-not-spread-virus.html
http://web.archive.org/web/
20150811132640/http://
www.modernghana.com/news/623885/
1/ebola-vaccine-trial-in-ghana-will-not-
spread-virus.html
Ebola vaccine trial in Ghana will not
spread virus- Health Minister
16.06a Starr FM
Online
http://www.starrfmonline.com/1.4539072 http://web.archive.org/web/
20150731051150/http://
www.starrfmonline.com/1.4539072
Ebola vaccine trial: MoH to start
sensitisation exercise Thursday
16.06a GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=362828
http://web.archive.org/web/
20150818045313/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=362828
Ebola vaccine trial sensitisation begins
on Thursday
16.06b Starr FM
Online
http://www.starrfmonline.com/1.4532392 http://web.archive.org/web/
20150731052609/http://
www.starrfmonline.com/1.4532392
Parliament summons Alex Dodoo over
Ebola attack
16.06b GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=362780
http://web.archive.org/web/
20150818062611/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=362780
Health Minister faces Parliament on
botched Ebola vaccines trial
16.06c GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=362844
http://web.archive.org/web/
20150818065429/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=362844
Parliament summons Alex Dodoo over
‘Ebola attack’
16.06b Modern
Ghana
http://www.modernghana.com/news/
623899/1/parliament-summons-alex-
dodoo-over-ebola-attack.html
http://web.archive.org/web/
20150811133920/http://
www.modernghana.com/news/623899/
1/parliament-summons-alex-dodoo-over-
ebola-attack.html
Parliament Summons Alex Dodoo Over
Ebola Attack
16.06c Starr FM
Online
http://www.starrfmonline.com/1.4511176 http://web.archive.org/web/
20150731061132/http://
www.starrfmonline.com/1.4511176
Health Minister briefs Parliament on
botched Ebola vaccines trial
16.06c Modern
Ghana
http://www.modernghana.com/news/
623880/1/ebola-vaccine-trial-
sensitisation-to-begin-thursda.html
http://web.archive.org/web/
20150811133323/http://
www.modernghana.com/news/623880/
1/ebola-vaccine-trial-sensitisation-to-
begin-thursda.html
Ebola vaccine trial sensitisation to begin
Thursday
16.06 Ghanaian
Times
http://www.ghanaiantimes.com.gh/
kudos-to-the-ghana-academy-of-arts-
and-sciences/
http://web.archive.org/web/
20170727165350/http://
www.ghanaiantimes.com.gh/kudos-to-
the-ghana-academy-of-arts-and-sciences/
Kudos to the Ghana Academy of Arts
and Sciences - The Ghanaian Times
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17.06 Ghanaian
Times
http://www.ghanaiantimes.com.gh/prof-
dodoo-to-be-dragged-before-house/
http://web.archive.org/web/
20170727164558/http://
www.ghanaiantimes.com.gh/prof-dodoo-
to-be-dragged-before-house/
Prof. Dodoo to be dragged before
House - The Ghanaian Times
17.06a Modern
Ghana
http://www.modernghana.com/news/
624082/1/minister-raps-mps-over-ebola-
for-phone.html
http://web.archive.org/web/
20150811204225/http://
www.modernghana.com/news/624082/
1/minister-raps-mps-over-ebola-for-
phone.html
Minister Raps MPs Over Ebola For Phone
17.06b Modern
Ghana
http://www.modernghana.com/news/
623974/1/professor-dodoo-happy-to-
face-parliament-over-igno.html
http://web.archive.org/web/
20150811194328/http://
www.modernghana.com/news/623974/
1/professor-dodoo-happy-to-face-
parliament-over-igno.html
Professor Dodoo happy to face
parliament over ‘ignorant’ Ebola
comment
17.06c Modern
Ghana
http://www.modernghana.com/news/
623993/1/prof-dodoo-faces-mps-over-
ebola.html
http://web.archive.org/web/
20170727171553/https://
www.modernghana.com/news/623993/
1/prof-dodoo-faces-mps-over-ebola.html
Prof Dodoo Faces MPs Over Ebola
17.06 Vibeghana
(TV)
http://vibeghana.com/2015/06/17/ebola-
vaccine-test-has-not-started-in-ghana-
segbefia/
http://web.archive.org/web/
20160127205449/http://vibeghana.com/
2015/06/17/ebola-vaccine-test-has-not-
started-in-ghana-segbefia/
Ebola vaccine test has not started in
Ghana - Segbefia
17.06a GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=362957
http://web.archive.org/web/
20150818131209/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=362957
Prof. Dodoo happy to face parliament
17.06b GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
artikel.php?ID=362956
http://web.archive.org/web/
20150818120534/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/artikel.php?ID=362956
Prof. Dodoo summons ‘extremely
amusing’ - Noguchi official
17.06d Modern
Ghana
http://www.modernghana.com/news/
623980/1/todays-front-pages.html
http://web.archive.org/web/
20150811195402/http://
www.modernghana.com/news/623980/
1/todays-front-pages.html
Today’s Front Pages
17.06c GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/Bagbin-
tells-Prof-Dodoo-to-test-Ebola-vaccine-
first-363005
http://web.archive.org/web/
20150818130320/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/Bagbin-tells-Prof-Dodoo-to-
test-Ebola-vaccine-first-363005
Bagbin tells Prof Dodoo to test Ebola
vaccine first
18.06a GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/Let-s-
find-permanent-medical-solution-to-
Ebola-Segbefia-363156
http://web.archive.org/web/
20150818151639/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/Let-s-find-permanent-
medical-solution-to-Ebola-Segbefia-
363156
Let’s find permanent medical solution to
Ebola - Segbefia
18.06b GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/Ebola-
Vaccine-trial-sensitisation-starts-today-
363195
http://web.archive.org/web/
20150818171345/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/Ebola-Vaccine-trial-
sensitisation-starts-today-363195
Ebola Vaccine trial sensitisation starts
today
18.06a Modern
Ghana
http://www.modernghana.com/news/
624501/1/there-shall-be-no-wrong-
doing-under-our-watch-who-.html
http://web.archive.org/web/
20150811225334/http://
www.modernghana.com/news/624501/
1/there-shall-be-no-wrong-doing-under-
our-watch-who-.html
There shall be no wrong doing under
our watch: WHO on ebola trial in Ghana
18.06c GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
Parliament-summons-Blakk-Rasta-over-
wee-comments-363240
http://web.archive.org/web/
20150818170904/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/Parliament-summons-Blakk-
Rasta-over-wee-comments-363240
Parliament summons Blakk Rasta over
wee comments
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18.06b Modern
Ghana
http://www.modernghana.com/news/
624379/1/let-them-test-the-ebola-
vaccine-on-you-first-bagbi.html
http://web.archive.org/web/
20150811223021/http://
www.modernghana.com/news/624379/
1/let-them-test-the-ebola-vaccine-on-
you-first-bagbi.html
Let them test the Ebola vaccine on you
first - Bagbin tells Prof Dodoo
18.06c Modern
Ghana
http://www.modernghana.com/news/
624470/1/statement-to-parliament-on-
the-proposed-anti-ebola.html
http://web.archive.org/web/
20150811224325/http://
www.modernghana.com/news/624470/
1/statement-to-parliament-on-the-
proposed-anti-ebola.html
Statement to Parliament on the
proposed anti-Ebola vaccine clinical trials
in Ghana
18.06d GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/Ebola-
vaccine-test-has-not-started-in-Ghana-
Segbefia-363121
http://web.archive.org/web/
20150818165935/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/Ebola-vaccine-test-has-not-
started-in-Ghana-Segbefia-363121
Ebola vaccine test has not started in
Ghana – Segbefia
18.06e GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/features/Voltarians-
Beware-362878
http://web.archive.org/web/
20150818181226/http://
www.ghanaweb.com/GhanaHomePage/
features/Voltarians-Beware-362878
Voltarians Beware!!!
18.06d Modern
Ghana
http://www.modernghana.com/news/
624489/1/commentary-the-vaccination-
sc.html
http://web.archive.org/web/
20170727172320/https://
www.modernghana.com/news/624489/
1/commentary-the-vaccination-sc.html
Commentary: The Vaccination: Science
Or Pseudo-Science?
19.06 Press release from the World Health Organization (WHO) is assuring that the proposed Ebola vaccine trials will not put any Ghanaian at risk
of contracting the virus.
19.06 GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/Ebola-
trial-will-not-harm-Ghanaians-WHO-
assures-363426
http://web.archive.org/web/
20150819042333/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/Ebola-trial-will-not-harm-
Ghanaians-WHO-assures-363426
Ebola trial will not harm Ghanaians –
WHO assures
19.06a Modern
Ghana
http://www.modernghana.com/news/
624605/1/parliament-summons-blakk-
rasta-for-contemptuous-co.html
http://web.archive.org/web/
20150812031453/http://
www.modernghana.com/news/624605/
1/parliament-summons-blakk-rasta-for-
contemptuous-co.html
Parliament summons Blakk Rasta for
contemptuous comment
19.06b Modern
Ghana
http://www.modernghana.com/news/
624675/1/ebola-trial-not-harmful-who-
allays-fears.html
http://web.archive.org/web/
20150812025129/http://
www.modernghana.com/news/624675/
1/ebola-trial-not-harmful-who-allays-
fears.html
Ebola Trial Not Harmful–WHO Allays
Fears
19.06c Modern
Ghana
http://www.modernghana.com/news/
624544/1/sacrifice-for-ebola-vaccine-trial-
john-jinapor.html
http://web.archive.org/web/
20150812025257/http://
www.modernghana.com/news/624544/
1/sacrifice-for-ebola-vaccine-trial-john-
jinapor.html
Sacrifice For Ebola Vaccine Trial - John
Jinapor
19.06d Modern
Ghana
http://www.modernghana.com/music/
31009/3/blakk-rasta-hot-over-ganja-
mps.html
http://web.archive.org/web/
20150812031438/http://
www.modernghana.com/music/31009/3/
blakk-rasta-hot-over-ganja-mps.html
Blakk Rasta Hot Over Ganja MPs
20.06 Vibeghana
(TV)
http://vibeghana.com/2015/06/20/
ghana-ebola-trials-will-not-be-
compromised-clinical-researches/
http://web.archive.org/web/
20160128035159/http://vibeghana.com/
2015/06/20/ghana-ebola-trials-will-not-
be-compromised-clinical-researches/
Ghana: Ebola Trials will not be
compromised- Clinical researches
20.06 Modern
Ghana
http://www.modernghana.com/news/
624896/1/some-mps-were-ignorant-on-
ebola-trial-no-2-ways-ab.html
http://web.archive.org/web/
20150812073855/http://
www.modernghana.com/news/624896/
1/some-mps-were-ignorant-on-ebola-
trial-no-2-ways-ab.html
Some MPs were ignorant on Ebola trial,
no 2 ways about that - Baako
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Table 2 Analysed articles and major incidents (Continued)
21.06 GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/Some-
MPs-were-ignorant-on-Ebola-trial-Baako-
insists-363642
http://web.archive.org/web/
20150819132404/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/Some-MPs-were-ignorant-
on-Ebola-trial-Baako-insists-363642
Some MPs were ignorant on Ebola trial –
Baako insists
22.06a Ghanaian
Chronicle
http://thechronicle.com.gh/letting-my-
thoughts-ramble/
http://web.archive.org/web/
20170728071234/http://
thechronicle.com.gh/letting-my-
thoughts-ramble/
Letting My Thoughts Ramble Ghanaian
Chronicle
22.06b Ghanaian
Chronicle
http://thechronicle.com.gh/allowing-
ebola-vaccine-trial-shows-ndc-
insensitivity-chairman-wontumi/
https://web.archive.org/web/
20170728074302/http://
thechronicle.com.gh/allowing-ebola-
vaccine-trial-shows-ndc-insensitivity-
chairman-wontumi/
Allowing Ebola Vaccine Trial Shows NDC
Insensitivity -Chairman Wontumi
Ghanaian Chronicle
22.06 Modern
Ghana
http://www.modernghana.com/news/
625247/1/ebola-vaccine-trial-lead-
scientist-offers-to-be-us.html
http://web.archive.org/web/
20150812141310/http://
www.modernghana.com/news/625247/
1/ebola-vaccine-trial-lead-scientist-offers-
to-be-us.html
Ebola vaccine trial: Lead scientist offers
to be used for test
23.06a GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/Ebola-
vaccines-trial-Lead-scientist-offers-to-be-
used-for-test-364062
http://web.archive.org/web/
20150820003515/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/Ebola-vaccines-trial-Lead-
scientist-offers-to-be-used-for-test-364062
Ebola vaccines trial: Lead scientist offers
to be used for test
23.06b GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
Mahama-reasons-like-a-stone-age-man-
Chairman-Wontumi-364059
http://web.archive.org/web/
20150819230241/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/Mahama-reasons-like-a-
stone-age-man-Chairman-Wontumi-
364059
Mahama reasons like a stone age man -
Chairman Wontumi
23.06c GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
Allowing-Ebola-Vaccine-trial-shows-NDC-
insensitivity-Wontumi-364057
http://web.archive.org/web/
20150820021855/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/Allowing-Ebola-Vaccine-
trial-shows-NDC-insensitivity-Wontumi-
364057
Allowing Ebola Vaccine trial shows NDC
insensitivity - Wontumi
24.06d GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
Parliament-not-averse-to-criticism-
Bagbin-364304
http://web.archive.org/web/
20151219000216/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/Parliament-not-averse-to-
criticism-Bagbin-364304
Parliament not averse to criticism —
Bagbin
25.06 Ghanaian
Chronicle
http://thechronicle.com.gh/ebola-and-
ethics-autopsy-of-failure/
http://web.archive.org/web/
20170728072356/http://
thechronicle.com.gh/ebola-and-ethics-
autopsy-of-failure/
Ebola and ethics: Autopsy of Failure
Ghanaian Chronicle
27.06 GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/features/Who-must-
answer-to-GAAS-364910
http://web.archive.org/web/
20151228014451/http://
www.ghanaweb.com/GhanaHomePage/
features/Who-must-answer-to-GAAS-
364910
Who must answer to GAAS
30.06 Modern
Ghana
http://www.modernghana.com/news/
626935/1/on-ebola-flap-both-sides-are-
wrong.html
http://web.archive.org/web/
20150805081948/http://
www.modernghana.com/news/626935/
1/on-ebola-flap-both-sides-are-
wrong.html
On Ebola Flap, Both Sides Are Wrong
30.06 Ghanaian
Times
http://www.ghanaiantimes.com.gh/
when-scientists-become-too-secretive/
https://web.archive.org/web/
20170728073410/http://
www.ghanaiantimes.com.gh/when-
scientists-become-too-secretive/
When scientists become too ‘secretive’ -
The Ghanaian Times
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02.07 It becomes clear that Dodoo needs to face parliament after “ignorant”-statement
02.07 GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/Prof-
Dodoo-faces-Privileges-Committee-of-
Parliament-over-Ebola-ignorant-
comment-366040
http://web.archive.org/web/
20160127160832/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/Prof-Dodoo-faces-Privileges-
Committee-of-Parliament-over-Ebola-
ignorant-comment-366040
Prof. Dodoo faces Privileges Committee
of Parliament over Ebola ignorant
comment
02.07 Ghanaian
Chronicle
http://thechronicle.com.gh/who-must-
answer-to-gaas-the-world-health-
organisation-must-respond-to-the-
queries-of-the-ghana-academy-of-arts-
and-sciences/
http://web.archive.org/web/
20170728072617/http://
thechronicle.com.gh/who-must-answer-
to-gaas-the-world-health-organisation-
must-respond-to-the-queries-of-the-
ghana-academy-of-arts-and-sciences/
Who Must Answer To GAAS -(The World
Health Organisation Must Respond To
The Queries Of The Ghana Academy Of
Arts and Sciences) Ghanaian Chronicle
02.07 Ghanaian
Times
http://www.ghanaiantimes.com.gh/prof-
dodoo-to-face-parliament/
https://web.archive.org/web/
20170728073911/http://
www.ghanaiantimes.com.gh/prof-dodoo-
to-face-parliament/
Prof. Dodoo to face Parliament - The
Ghanaian Times
02.07 Starr FM
Online
http://www.starrfmonline.com/1.4926550 http://web.archive.org/web/
20151018033439/http://
www.starrfmonline.com/1.4926550
Prof. Dodoo ‘snubs’ Parliament over
Ebola attack
03.07 GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/features/On-Ebola-
Flap-Both-Sides-Are-Wrong-365443
http://web.archive.org/web/
20160128175024/http://
www.ghanaweb.com/GhanaHomePage/
features/On-Ebola-Flap-Both-Sides-Are-
Wrong-365443
On Ebola Flap, Both Sides Are Wrong
03.07 Ghanaian
Times
http://www.ghanaiantimes.com.gh/prof-
dodoo-fails-to-show-up/
https://web.archive.org/web/
20170728074054/http://
www.ghanaiantimes.com.gh/prof-dodoo-
fails-to-show-up/
Prof. Dodoo fails to show up - The
Ghanaian Times
05.07 GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/Doubts-
over-integrity-of-Ebola-trials-366573
http://web.archive.org/web/
20160129221421/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/Doubts-over-integrity-of-
Ebola-trials-366573
Doubts over integrity of Ebola trials
06.07 Starr FM
Online
http://www.starrfmonline.com/1.4994637 http://web.archive.org/web/
20151018040525/http://
www.starrfmonline.com/1.4994637
Public forum on Ebola vaccine trial
opens in Ho today
07.07 Starr FM
Online
http://www.starrfmonline.com/1.5012492 http://web.archive.org/web/
20151018041412/http://
www.starrfmonline.com/1.5012492
Mothers flee from child immunisation
over Ebola vaccine trial fears
08.07 Starr FM
Online
http://www.starrfmonline.com/1.5051024 http://web.archive.org/web/
20151018042225/http://
www.starrfmonline.com/1.5051024
Ebola vaccine trials volunteers promised
Int’l insurance cover - GHS
08.07 GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/features/Ebola-
Vaccine-Components-Do-Not-Cause-
Ebola-Disease-367172
http://web.archive.org/web/
20150810134504/http://
www.ghanaweb.com/GhanaHomePage/
features/Ebola-Vaccine-Components-Do-
Not-Cause-Ebola-Disease-367172
Ebola Vaccine Components Do Not
Cause Ebola Disease!
14.07 Modern
Ghana
http://www.modernghana.com/news/
629627/1/i-didnt-insult-you-but-if-you-
feel-insulted-im-sor.html
http://web.archive.org/web/
20150811185341/http://
www.modernghana.com/news/629627/
1/i-didnt-insult-you-but-if-you-feel-
insulted-im-sor.html
I didn’t insult you but if you feel insulted
I’m sorry; Prof. Dodoo tells MPs
14.07 Starr FM
Online
http://www.starrfmonline.com/1.5213802 http://web.archive.org/web/
20151018051109/http://
starrfmonline.com/1.5213802
Prof. Dodoo apologises to Parliament
15.07 GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/world/Trials-of-Ebola-
vaccines-begin-in-Europe-and-Senegal-
368838
http://web.archive.org/web/
20150819010237/http://
www.ghanaweb.com/GhanaHomePage/
world/Trials-of-Ebola-vaccines-begin-in-
Europe-and-Senegal-368838
Trials of Ebola vaccines begin in Europe
and Senegal
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15.07 GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/MPs-
cannot-be-criticised-for-comments-in-
the-House-368705
http://web.archive.org/web/
20150818182624/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/MPs-cannot-be-criticised-
for-comments-in-the-House-368705
‘MPs cannot be criticised for comments
in the House’
16.07 Modern
Ghana
http://www.modernghana.com/news/
630092/1/live-updateround-two-
privileges-committee-hears-ca.html
http://web.archive.org/web/
20150812165301/http://
www.modernghana.com/news/630092/
1/live-updateround-two-privileges-
committee-hears-ca.html
Live Update: Round Two: Privileges
Committee hears case against Prof
Dodoo
16.07a GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/Prof-
Dodoo-eats-back-his-words-369158
http://web.archive.org/web/
20150819231335/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/Prof-Dodoo-eats-back-his-
words-369158
Prof. Dodoo eats back his words
16.07b GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/You-are-
completely-ignorant-Lawyer-dares-MPs-
369161
http://web.archive.org/web/
20150819221331/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/You-are-completely-
ignorant-Lawyer-dares-MPs-369161
You are completely ignorant - Lawyer
dares MPs
16.07 Starr FM
Online
http://www.starrfmonline.com/1.5277489 http://web.archive.org/web/
20151018052658/http://
www.starrfmonline.com/1.5277489
I don’t object to Ebola vaccine trial’ -
Hohoe Chief
17.07a GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/Speaker-
vetoes-MPS-charge-at-Prof-Dodoo-
369214
http://web.archive.org/web/
20150820063142/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/Speaker-vetoes-MPS-
charge-at-Prof-Dodoo-369214
Speaker vetoes MPS ‘charge’ at Prof
Dodoo
17.07b GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/Hohoe-
welcomes-Ebola-vaccine-trial-369169
http://web.archive.org/web/
20150820045037/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/Hohoe-welcomes-Ebola-
vaccine-trial-369169
Hohoe welcomes Ebola vaccine trial
17.07 Modern
Ghana
http://www.modernghana.com/news/
630238/1/hohoe-paramount-chief-
welcomes-ebola-vaccine-trial.html
https://web.archive.org/web/
20170728073700/https://
www.modernghana.com/news/630238/
1/hohoe-paramount-chief-welcomes-
ebola-vaccine-trial.html
Hohoe Paramount Chief welcomes Ebola
vaccine trial in his town
18.07a GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/features/We-can-t-
fight-EBOLA-with-Substance-Abuse-the-
Ignorance-is-too-much-369444
http://web.archive.org/web/
20150820094544/http://
www.ghanaweb.com/GhanaHomePage/
features/We-can-t-fight-EBOLA-with-
Substance-Abuse-the-Ignorance-is-too-
much-369444
We can’t fight EBOLA with Substance
Abuse, the Ignorance is too much
18.07b GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/We-
were-not-told-to-halt-Ebola-Vaccine-trial-
FDA-369485
http://web.archive.org/web/
20150926200441/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/We-were-not-told-to-halt-
Ebola-Vaccine-trial-FDA-369485
We were not told to halt Ebola Vaccine
trial – FDA
18.07c GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/FDA-
gives-evidence-in-Parliament-369401
http://web.archive.org/web/
20150820084113/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/FDA-gives-evidence-in-
Parliament-369401
FDA gives evidence in Parliament
19.07 GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/features/Of-politics-
politicians-and-arrogance-as-MPs-belittle-
our-intelligence-369559
http://web.archive.org/web/
20150820141131/http://
www.ghanaweb.com/GhanaHomePage/
features/Of-politics-politicians-and-
arrogance-as-MPs-belittle-our-
intelligence-369559
Of politics, politicians and arrogance…as
MPs belittle our intelligence
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22.07 GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
Parliament-invites-Prof-Dodoo-again-
370229
http://web.archive.org/web/
20150821115625/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/Parliament-invites-Prof-
Dodoo-again-370229
Parliament invites Prof Dodoo again
22.07 Starr FM
Online
http://www.starrfmonline.com/1.5391166 http://web.archive.org/web/
20151018061259/http://
www.starrfmonline.com/1.5391166
Parliament summons apologetic Prof.
Dodoo again
22.07a Modern
Ghana
http://www.modernghana.com/news/
631141/1/john-jinapor-must-apologize-
to-ghanaians-for-insul.html
http://web.archive.org/web/
20150927001932/http://
www.modernghana.com/news/631141/
1/john-jinapor-must-apologize-to-
ghanaians-for-insul.html
John Jinapor Must Apologize to
Ghanaians for Insulting our Intelligence
for His Ebola vaccine Trials
22.07b Modern
Ghana
http://www.modernghana.com/news/
631326/1/parliament-summons-
apologetic-prof-dodoo-again.html
http://web.archive.org/web/
20150814220725/http://
www.modernghana.com/news/631326/
1/parliament-summons-apologetic-prof-
dodoo-again.html
Parliament Summons Apologetic Prof.
Dodoo again
22.07 GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
Parliament-to-determine-Prof-Dodoo-s-
fate-Thursday-370087
http://web.archive.org/web/
20150821122358/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/Parliament-to-determine-
Prof-Dodoo-s-fate-Thursday-370087
Parliament to determine Prof Dodoo’s
fate Thursday
23.07 Modern
Ghana
http://www.modernghana.com/news/
631507/1/judgement-day-prof-dodoo-
blakk-rasta-meet-mps-toda.html
http://web.archive.org/web/
20150815055738/http://
www.modernghana.com/news/631507/
1/judgement-day-prof-dodoo-blakk-rasta-
meet-mps-toda.html
Judgement Day: Prof Dodoo, Blakk Rasta
meet MPs today
23.07a GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/
Judgement-Day-Prof-Dodoo-Blakk-Rasta-
meet-MPs-today-370425
http://web.archive.org/web/
20150821172033/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/Judgement-Day-Prof-
Dodoo-Blakk-Rasta-meet-MPs-today-
370425
Judgement Day: Prof Dodoo, Blakk Rasta
meet MPs today
24.07b GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/Prof-
Dodoo-pardoned-discharged-370790
http://web.archive.org/web/
20150821234551/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/Prof-Dodoo-pardoned-
discharged-370790
Prof Dodoo pardoned, discharged
24.07 Starr FM
Online
http://www.starrfmonline.com/1.5483817 http://web.archive.org/web/
20151018062756/http://
starrfmonline.com/1.5483817
Parliament pardons Prof. Dodoo
25.07a Modern
Ghana
http://www.modernghana.com/news/
632044/1/is-parliament-becoming-a-
monster-ghana-connect-ask.html
http://web.archive.org/web/
20150815205706/http://
www.modernghana.com/news/632044/
1/is-parliament-becoming-a-monster-
ghana-connect-ask.html
Is Parliament becoming a Monster?
Ghana Connect asks
25.07b Modern
Ghana
http://www.modernghana.com/news/
631987/1/give-me-275-slaps-8211-blakk-
rasta-tells-mps.html
http://web.archive.org/web/
20150815213650/http://
www.modernghana.com/news/631987/
1/give-me-275-slaps-8211-blakk-rasta-
tells-mps.html
Give Me 275 Slaps – Blakk Rasta Tells
MPs
25.07c Modern
Ghana
http://www.modernghana.com/news/
631940/1/professor-dodoo-escapes-
wrath-of-parliament.html
https://web.archive.org/web/
20170728073814/https://
www.modernghana.com/news/631940/
1/professor-dodoo-escapes-wrath-of-
parliament.html
Professor Dodoo Escapes Wrath Of
Parliament
25.07 GhanaWeb http://www.ghanaweb.com/
GhanaHomePage/NewsArchive/Give-me-
275-slaps-Blakk-Rasta-tells-MPs-370894
http://web.archive.org/web/
20150822030254/http://
www.ghanaweb.com/GhanaHomePage/
NewsArchive/Give-me-275-slaps-Blakk-
Rasta-tells-MPs-370894
Give me 275 slaps – Blakk Rasta tells MPs
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